AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 57 filers reported holding AKCEA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $111,000 | +38.8% | 6,134 | +5.3% | 0.00% | – |
| Q2 2020 | $80,000 | +23.1% | 5,825 | +29.2% | 0.00% | – |
| Q1 2020 | $65,000 | -28.6% | 4,507 | -17.0% | 0.00% | – |
| Q4 2019 | $91,000 | +8.3% | 5,427 | -0.8% | 0.00% | – |
| Q3 2019 | $84,000 | -24.3% | 5,473 | +13.8% | 0.00% | – |
| Q2 2019 | $111,000 | -15.9% | 4,811 | +4.0% | 0.00% | – |
| Q1 2019 | $132,000 | -5.7% | 4,625 | -0.6% | 0.00% | – |
| Q4 2018 | $140,000 | -7.9% | 4,653 | +7.0% | 0.00% | – |
| Q3 2018 | $152,000 | +49.0% | 4,349 | +0.7% | 0.00% | – |
| Q2 2018 | $102,000 | -15.7% | 4,318 | -8.8% | 0.00% | – |
| Q1 2018 | $121,000 | -19.3% | 4,735 | -45.4% | 0.00% | – |
| Q4 2017 | $150,000 | +102.7% | 8,667 | +230.9% | 0.00% | – |
| Q3 2017 | $74,000 | – | 2,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |